Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure

Chest

Volumn 118, Issue 4, 2000, Pages 914-922

  Mathew, J ^a,b   Hunsberger, S ^a   Fleg, J ^a   McSherry, F ^a   Williford, W ^a   Yusuf, S ^a  

^a Cook Country Hospital ^*

^b Jr Hospital of Cook County   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Atrial fibrillation; Congestive heart failure; Digoxin; Stroke; Supraventricular arrhythmia

Indexed keywords

DIGOXIN; PLACEBO;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; SINUS RHYTHM; STROKE; SUPRAVENTRICULAR TACHYCARDIA;

EID: 0033793363     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)81588-X     Document Type: Article

References (27)

1. Epidemiologic features of chronic atrial fibrillation
2. Independent risk factors for atrial fibrillation in a population-based cohort
3. The influence of atrial fibrillation on prognosis in mild to moderate heart failure
4. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular dysfunction: A retrospective analysis of the SOLVD Trials
5. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: A large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure
6. The effect of digoxin on mortality and morbidity in patients with heart failure
7. A nomogram for digoxin therapy
8. Impact of atrial fibrillation on the risk of death: The Framingham heart study
9. The relationship between cardiothoracic ratio and left ventricular ejection fraction in congestive heart failure
10. Changes in hypertension treatment and in congestive heart failure mortality in the United States
11. Etiology and characteristics of congestive heart failure in blacks
12. Prognostic significance of atrial fibrillation in advanced heart failure
13. Atrial fibrillation as an independent risk factor for stroke: The Framingham study
14. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
15. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction: SOLVD (Studies of Left Ventricular Dysfunction) Investigators
16. Atrial fibrillation: Current understandings and research imperatives
17. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction
18. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction
19. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
20. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized controlled trials
21. Coronary heart disease and atrial fibrillation: The Framingham study
22. The natural history of lone atrial fibrillation
23. Special report: Preliminary report of the Stroke Prevention in Atrial Fibrillation study
24. Stroke Prevention in Atrial Fibrillation study: Final results
25. Canadian atrial fibrillation anticoagulation (CAFA) study
26. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASK study
27. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation